LANDRY DONALD W

CIK 00015636162 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001563616

Recent Transactions

34 trades

Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2025-04-24+1,386→ 10,460.189 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2025-04-24$80.14/sh−619→ 9,841.189 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2024-04-25+1,436→ 9,149.917 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2024-04-25$69.64/sh−271→ 8,878.917 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2023-04-27$73.70/sh−701→ 7,522.195 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2023-04-27+1,222→ 8,223.195 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2022-04-28$84.98/sh−591→ 6,857.083 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2022-04-28+1,060→ 7,448.083 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2021-04-22$81.51/sh−772→ 6,272.996 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2021-04-22+1,105→ 7,044.996 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2020-04-23+2,041→ 6,405.635 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2020-04-23$44.10/sh−612→ 5,793.635 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2019-05-06+30,000→ 30,000 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2019-04-25$69.60/sh−584→ 4,258.272 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2019-04-25+1,282→ 4,842.272 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2018-06-12+20,000→ 20,000 total
Tax Payment
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2018-04-26$67.90/sh−298→ 3,487.432 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2018-04-26+1,310→ 3,785.432 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2017-06-20+20,000→ 20,000 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-05-27−750→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-05-27+750→ 9,210 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2017-04-27+1,081→ 2,434.332 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2017-02-09−750→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2017-02-09+750→ 8,460 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-05-27+7,500→ 7,500 total
Award
SENSIENT TECHNOLOGIES CORP$SXT
Common Stock
2016-04-21+1,333→ 1,333 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Units
2016-02-25−600→ 0 total
Exercise/Conversion
Tonix Pharmaceuticals Holding Corp.$TNXP
Common Stock, $0.001 par value
2016-02-25+600→ 7,710 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2016-02-09+7,500→ 7,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Restricted Stock Unit
2015-02-25+6,000→ 6,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2015-02-25+5,000→ 5,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-10-29+5,000→ 5,000 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2014-02-11+5,500→ 5,500 total
Award
Tonix Pharmaceuticals Holding Corp.$TNXP
Stock Option
2013-02-12+210,000→ 0 total

Companies

Recent Filings

Address

C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., STE 306

NEW YORK, NY, 10022

View on SEC.gov